LABORATORY AND CLINICAL STUDIES OF CEFADROXIL IN OPHTHALMOLOGIC FIELD

Cefadroxil, a new cephalosporin antibiotic, has an antibacterial activity similar to that of cephalexin (CEX). Sensitivity of 15 strains of Staph. aureus isolated clinically was distributed between 1.56-6.25μg/ml, and the peak of 3.13μg/ml was noticed in 8 strains (53.3%). Three healthy volunteers w...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 28; no. Supplement2; pp. 499 - 505
Main Authors OISHI, MASAO, NISHIZUKA, KENJI, MOTOYAMA, MARIKO, OGAWA, TAKESHI, NAGAI, SHIGEO
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 1980
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cefadroxil, a new cephalosporin antibiotic, has an antibacterial activity similar to that of cephalexin (CEX). Sensitivity of 15 strains of Staph. aureus isolated clinically was distributed between 1.56-6.25μg/ml, and the peak of 3.13μg/ml was noticed in 8 strains (53.3%). Three healthy volunteers were administered orally 500mg of the agent at fasting early in the morning, and the average peak value of 12.93μg/ml was obtained after 2 hours, then decreasing gradually, the average level was 2.16μg/ml after 6 hours. Intraocular penetration was determined in white mature rabbit. A dose of 50mg/kg was administered orally, and the peak value in aqueous humor was 1.73μg/ml after 2 hours, aqueous humor/serum ratio being 20.11%. The ocular tissue levels were transferred well too in outer and inner parts of the eyes after 2 hours. A dose of 250mg or 500mg of the agent was administered clinically per os 3 times per day in 20 cases of various bacterial infections of eye, and the result obtained was excellent in 3 cases, good in 11 cases, fair in 4 cases, poor in 1 case, and unknown in 1 case. As to the side effect of the agent, 1 case complained of diarrheic symptoms, and the administration was interrupted. No other effects as allergic reaction were observed.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.28.Supplement2_499